Ultrasonic Medical Mapping utilizes aerospace-derived ultrasonic technology to detect pancreatic cancers at an early stage. This approach enhances diagnostic accuracy and reduces the costs associated with traditional cancer detection methods.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pancreatic cancer is difficult to detect in its early stages using conventional methods, leading to delayed diagnoses and poorer patient outcomes. Existing diagnostic techniques can be costly, invasive, and may lack the sensitivity needed to identify small tumors.
Solution
Ultrasonic Medical Mapping offers an innovative approach to early pancreatic cancer detection by leveraging aerospace-derived ultrasonic technology. This technology aims to improve diagnostic accuracy and enable earlier intervention, potentially leading to better treatment outcomes and increased survival rates. The method focuses on providing a more cost-effective and efficient means of identifying pancreatic tumors compared to traditional screening and diagnostic procedures. By enhancing the ability to detect cancer at an early stage, Ultrasonic Medical Mapping seeks to address the critical need for improved diagnostic tools in pancreatic cancer management.
Target Audience
The primary target audience includes healthcare providers, oncologists, and hospitals seeking advanced diagnostic tools for early pancreatic cancer detection, as well as individuals at high risk for pancreatic cancer.
Features
- Aerospace-derived ultrasonic technology for enhanced imaging.
- Non-invasive detection method.
- Early-stage pancreatic cancer detection.
- Cost-effective diagnostic solution.